Both are liposomal AHK-Cu formulations using the same encapsulation technology
Jocelyn Solis-Moreira, MS is the associate health & fitness for Men's Health and has previously written for CNN, Scientific American, Popular Science , and National Geographic before joining the brand
Upcoming Surgery: Given effects on blood vessel formation and tissue healing, discontinuing BPC-157 at least two weeks before planned surgery is prudent
Based on investigational protocol reports and the clinical trial data, most subjects begin to see measurable changes in body composition at 4 to 6 weeks on a consistent daily protocol at 300 mcg
Studies suggest that BPC-157 may accelerate wound healing and support the repair of muscles, tendons, and ligaments
AOD9064 AOD9064 is a modified fragment of growth hormone designed specifically to support fat metabolism without many of the proliferative effects associated with full growth hormone activity